Skip to main content
Medical Reference · Condition Monograph

Meningitis

뇌수막염

Meningitis is a disease in which inflammation develops in the membranes (meninges) that surround and protect the brain and spinal cord.

History

Meningitis is a disease in which inflammation develops in the membranes (meninges) that surround and protect the brain and spinal cord. Because its symptoms can begin suddenly and worsen rapidly, it has long been known as a dangerous disease. In the past, even when high fever, severe headache, and a stiff neck appeared, it was difficult to identify the cause precisely, and the means of treatment were limited. Over time, it became clear that meningitis can arise from viruses, bacteria, tuberculosis bacteria, fungi, and parasites, as well as from noninfectious causes such as drugs, cancer, and autoimmunity.

An important turning point in the history of diagnosis was when lumbar puncture (a test that draws cerebrospinal fluid from the lower back) became standardized. Examining the cerebrospinal fluid directly provides clues as to whether the meningitis is bacterial, viral, or tuberculous, and the direction of treatment changes greatly. Later, as antibiotics, antiviral drugs, and adjunctive steroid therapy developed, mortality and residual disability decreased.

Another major change was prevention. As vaccination against major causative bacteria such as pneumococcus, meningococcus, and Haemophilus influenzae type b spread, certain types of bacterial meningitis decreased greatly in some regions. In recent research, technologies such as genetic detection in cerebrospinal fluid, multiplex pathogen panel tests, and next-generation sequencing of cerebrospinal fluid have been expanding to reduce diagnostic delays, and observations have also accumulated that environmental changes such as social distancing affect the prevalence of the organisms that cause meningitis.

Causes

The causes of meningitis can be broadly divided into infectious and noninfectious. Infectious causes include bacteria, viruses, tuberculosis bacteria, fungi, and parasites. Noninfectious causes include cancer spreading to the meninges, subarachnoid hemorrhage, chronic inflammatory diseases such as sarcoidosis, autoimmune diseases such as systemic lupus erythematosus, and certain drug reactions.

Bacterial meningitis progresses rapidly and carries a high level of risk. The causative bacteria vary with age. In newborns, group B streptococcus, Escherichia coli, and Listeria are important; in children, meningococcus, pneumococcus, and (in areas with insufficient vaccination) Haemophilus influenzae type b are a concern. In adults, meningococcus and pneumococcus are common, and in older adults the risk of Listeria increases. When there is head trauma, brain surgery, or a device such as a cerebrospinal fluid drain, pathogens such as Staphylococcus or Pseudomonas aeruginosa can be the cause.

Viral meningitis often has a relatively good prognosis, but it is difficult to distinguish from bacterial meningitis in the early stages. Enteroviruses are the most common, and herpesviruses, varicella-zoster virus, mumps virus, human immunodeficiency virus, and others can be causes. Tuberculous meningitis progresses slowly, and because its diagnosis is easily delayed, the risk of sequelae is high; fungal meningitis is a particular problem in immunocompromised states.

Genetic Epidemiology

In meningitis, it is more appropriate to understand heredity not in the sense that "a person will definitely get it if exposed to a specific pathogen," but in the sense that it creates individual differences in the immune response, which can make a person more vulnerable to infection or change the severity. Some people rarely become infected even in the same environment, while others progress to severe disease even after relatively light exposure. Genetic factors may influence this difference, along with age, underlying diseases, vaccination history, and immune status.

Typically, it is known that people with immune system abnormalities such as complement deficiency can have recurrent meningococcal infections. In addition, the view has been put forward that differences in some immune-related genes may change the intensity of the inflammatory response and increase brain damage. Recent research has emphasized that in bacterial meningitis, not only "the virulence of the pathogen" but also "the vulnerability of the host" has a major influence on prognosis.

From the general public's point of view, the practical message of genetic epidemiology is limited. Vaccination, exposure management, and early treatment have a greater influence on meningitis than heredity. Nevertheless, in cases of recurrent meningococcal infection or an unusually strong family history, immune evaluation and counseling can be helpful.

General Epidemiology

Meningitis occurs worldwide, and its causes and outbreak patterns vary by region and period. Bacterial meningitis has decreased in regions where vaccination is well implemented, but it can still be fatal, and the burden is heavy in regions where vaccines are less widely available. The so-called "meningitis belt" of sub-Saharan Africa is well known for repeated outbreaks during the dry season.

Viral meningitis is reported as the most common form in many countries and tends to increase in summer and autumn along with enterovirus epidemics. In recent research, it has been observed that during the COVID-19 pandemic, meningitis related to enteroviruses, meningococcus, pneumococcus, and Haemophilus influenzae decreased owing to factors such as social distancing, mask wearing, and reduced movement, followed by a "rebound" in which it increased again afterward.

An important point in understanding the epidemiology of meningitis is the fact that "meningitis = one disease" is not true. Even within meningitis, treatment, contagiousness, and the risk of sequelae differ completely depending on the cause. Therefore, vaccination and hygiene policies in the community, and rapid differentiation and immediate treatment in clinical settings, are key to reducing the epidemiological burden.

Pathogenesis

Meningitis begins when pathogens or inflammation-inducing factors enter the cerebrospinal fluid space. In bacterial meningitis, bacteria that commonly live on the mucous membranes of the nose and throat enter the bloodstream and invade the cerebrospinal fluid space through areas where the blood-brain barrier is vulnerable. Alternatively, they may enter directly through skull fractures, adjacent infections such as sinusitis, or devices such as cerebrospinal fluid drains. Viruses can also enter through the bloodstream or invade the central nervous system along nerve pathways.

The problem is that the damage caused by the pathogen itself and the immune response that tries to eliminate it together injure the brain. When bacterial and viral components stimulate immune receptors, inflammatory substances increase rapidly and white blood cells flock into the cerebrospinal fluid space. This process is necessary to suppress the infection, but when excessive, it causes brain edema, vascular inflammation, blood clots, increased intracranial pressure, and impaired cerebral blood flow, leaving neurological damage.

In tuberculous meningitis, progression is slower, but as sticky inflammatory material accumulates at the base of the brain, the flow of cerebrospinal fluid can be blocked, causing hydrocephalus, or cerebral vasculitis can cause cerebral infarction. Fungal meningitis progresses slowly in immunocompromised states, and the inflammation can persist chronically.

Recent research has emphasized that the interaction between host and pathogen determines prognosis and that "secondary brain injury" grows the more diagnosis and treatment are delayed. Rapid diagnosis and immediate initiation of treatment are the most important factors determining prognosis.

Symptoms

The typical symptoms of meningitis are fever, severe headache, and neck stiffness. These may be accompanied by vomiting, sensitivity to light (glare), sensitivity to sound, and changes in consciousness (dazedness, confusion). However, this "classic triad" does not appear simultaneously in all patients, which makes early diagnosis difficult.

In bacterial meningitis, symptoms can begin abruptly and worsen rapidly. High fever and chills, extreme headache, and decreased consciousness occur, and when sepsis accompanies it, blood pressure can drop and the overall condition can deteriorate rapidly. In meningococcal infection, red spots that do not fade when pressed may appear on the skin.

In viral meningitis, symptoms are relatively mild and changes in consciousness are often less pronounced, but there are exceptions. In tuberculous meningitis, headache, fever, and malaise continue gradually over days to weeks, and then changes in consciousness, seizures, and nerve palsies may gradually appear. In infants and young children, symptoms are more nonspecific and may appear only as fussiness, lethargy, or decreased feeding, and in older adults and immunocompromised people, typical symptoms may also appear only weakly, so caution is needed.

Signs

Important signs on examination are "meningeal irritation signs" such as neck stiffness, Kernig's sign, and Brudzinski's sign. However, because these tests have low sensitivity, meningitis cannot be ruled out just because the signs are absent. Conversely, when certain signs are clear, they strongly suggest the possibility of meningitis.

Changes in consciousness, seizures, focal neurological deficits (weakness on one side, slurred speech, visual field abnormalities), and cranial nerve palsies (double vision, facial paralysis, hearing loss) are signs suggesting severe disease. In infants, a bulging anterior fontanelle can be a clue.

Skin findings are also important. In meningococcal infection, the spots increase rapidly and, in severe cases, can progress to skin necrosis. Findings such as low blood pressure, increased respiratory rate, elevated pulse, and cold extremities suggest the possibility of accompanying sepsis, and when these signs appear, immediate emergency treatment is needed.

Screening

The key to screening is "not delaying the moment meningitis is suspected." When fever and headache occur together and the neck is stiff or consciousness becomes clouded, meningitis should be considered first. Greater vigilance is especially needed for immunocompromised people, infants and young children, older adults, people after head trauma or brain surgery, and those with cerebrospinal fluid devices.

In the emergency department, severity is assessed with vital signs, basic blood tests (inflammatory markers, white blood cells, electrolytes, liver and kidney function) and blood cultures are performed, and the patient is moved on to cerebrospinal fluid testing as quickly as possible. If neurological abnormalities are pronounced or increased intracranial pressure is suspected, imaging may be considered first, but if lumbar puncture is delayed by unnecessary imaging, the prognosis can worsen.

Recent research has emphasized that blood markers (e.g., procalcitonin, C-reactive protein) can help gauge the likelihood of bacterial meningitis, but they cannot replace confirmation on their own, and cerebrospinal fluid testing is key. The most important thing in screening is to move on to evaluation by a specialist immediately upon suspicion.

Diagnosis

The standard for diagnosis is analysis of cerebrospinal fluid obtained by lumbar puncture. The cause is estimated by combining the white blood cell count and type (neutrophils/lymphocytes), protein, glucose (ratio to blood glucose), lactate level, Gram stain and culture, and genetic testing (polymerase chain reaction) of the cerebrospinal fluid. In bacterial meningitis, increased neutrophils, elevated protein, and decreased glucose are common; in viral meningitis, increased lymphocytes are common and glucose tends to be relatively preserved. In tuberculous meningitis, lymphocyte predominance, elevated protein, and decreased glucose may appear.

Brain imaging (brain computed tomography or brain magnetic resonance imaging) helps assess brain edema, hydrocephalus, brain abscess, and complications, and helps determine whether lumbar puncture can be performed safely. Blood tests and blood cultures help determine whether sepsis is present and guide the choice of antibiotics.

Recent research has reported that multiplex pathogen cerebrospinal fluid panel tests and next-generation sequencing can increase the rate at which the cause is identified. However, no test should be a reason to delay "starting treatment." Testing and treatment should proceed as simultaneously as possible.

Treatment

Treatment differs by cause, but the common principle is "start treatment immediately when it is suspected." When bacterial meningitis is suspected, lumbar puncture and blood cultures are performed as quickly as possible, and then empirical antibiotics are administered without waiting for the results. When the causative organism and susceptibility results come in, the antibiotics are adjusted. In some types of bacterial meningitis, a strategy of using a steroid (dexamethasone) early together with antibiotics is used to reduce complications caused by inflammation.

Viral meningitis is mostly managed with symptomatic treatment (fluids, fever reduction, pain control), but when herpesvirus or varicella-zoster virus is suspected, antiviral drugs are administered early. Tuberculous meningitis requires the use of several antituberculosis drugs over a long period, and adjunctive steroid therapy can help the prognosis. Fungal meningitis requires antifungal drugs, and addressing the immunocompromised state is important.

In severe cases, intensive care is needed, such as management of intracranial pressure, treatment of seizures, respiratory and circulatory support, and drainage in cases of hydrocephalus. Recent research has reported that adjunctive treatments are being studied to reduce "secondary brain injury," which is difficult to reduce with antibiotics alone. Because the duration and method of treatment vary greatly depending on the cause, a specialist's judgment is essential.

Prognosis

The prognosis depends greatly on the cause and the timing of the start of treatment. Recovery from viral meningitis is generally good, but in some people headache, fatigue, and reduced concentration may last a long time. Bacterial meningitis carries a high risk of death and sequelae even with treatment, and especially when treatment is delayed, complications such as hearing loss, seizures, hydrocephalus, and cognitive decline may remain.

Meningococcal infection can worsen rapidly when accompanied by sepsis, and serious complications such as skin necrosis and limb amputation can occur. Because tuberculous meningitis progresses slowly, diagnosis tends to be delayed and the prognosis is prone to worsen, and cerebral infarction and hydrocephalus can leave sequelae. Fungal meningitis requires long-term treatment in immunocompromised states, and the risk of recurrence must also be considered.

Recent research has emphasized that although overall mortality has decreased through vaccination and public health measures, changes in circulating strains, diagnostic delays, and disparities in access to treatment are key factors determining prognosis. Even after survival, long-term follow-up and rehabilitation for neurological sequelae are important.

Prevention

The keys to prevention are vaccination and exposure management. Vaccination against vaccine-preventable causes such as pneumococcus, meningococcus, Haemophilus influenzae type b, and mumps greatly reduces the burden of meningitis. It is especially important for children, adolescents, people living in group settings, and immunocompromised people to follow vaccination recommendations closely.

For some types of bacterial meningitis (especially meningococcal), administering prophylactic antibiotics to close contacts can help block transmission. Hand hygiene, cough etiquette, and food and water hygiene contribute to reducing some infections (particularly parasitic and bacterial risks in certain regions). For the prevention of tuberculous meningitis, early detection and treatment of tuberculosis and care for vulnerable populations are important.

An important form of prevention at the individual level is "early response." If there is high fever, severe headache, neck stiffness, or a change in consciousness, emergency evaluation should be sought without delay.

Recent research has emphasized that nonpharmaceutical public health measures such as social distancing can also affect the prevalence of the organisms that cause meningitis, and that surveillance and vaccine strategies that take into account even the possibility of a subsequent rebound are needed. Checking one's vaccination history and completing vaccinations according to the latest recommendations is the most effective method of prevention.

This content is provided for general medical information only and does not replace individual diagnosis or treatment. If symptoms persist, please consult a medical professional.